Bristol Warns Physicians Of Early Virologic Failure With Videx EC Regimens
This article was originally published in The Pink Sheet Daily
Executive Summary
"Dear Doctor" letter recommends "caution" when co-administering Videx EC, Gilead's Viread and Bristol's Sustiva or BI's Viramune in treatment-naïve HIV patients with high viral loads. The virologic data could eventually be included in labeling, Bristol says.